Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Today

Executive Summary

Sponge is now "leading brand in the vaginal contraceptive category in both dollars and units sold to drugstores," VLI said in May 11 first quarter report to shareholders. Nearly 13 mil. sponges have been sold to about 500,000 users. For quarter ended March 31 VLI volume increased about 45% to $3.4 mil.; the firm showed net earnings of $305,027 v. a $32,817 loss in same quarter last year.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS006627

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel